News & Media

FIT awards first lifetime achievement award to J&J

17/04/2013

news item On Tuesday 16 April 2013 Tom Heyman received the first Lifetime Achievement Award from Flanders Investment & Trade (FIT), the independent Flemish agency charged with assisting companies with their global exports and attracting foreign investment, from the hands of Flemish Minister-President Kris Peeters. Johnson & Johnson received this award because of its decades-long confidence in our country and its consistent policy of investing in Flanders and Belgium. Read more

Janssen Pharmaceutica opens its doors for the first time in many years

12/03/2013

news item On Sunday 17 March, the care and health sector is organising the Dag van de Zorg (or Healthcare Open Day). Care and health organisations, educational institutes, research centres and companies in Flanders which are active in healthcare will open their doors. Janssen Pharmaceutica is also taking part and welcomes the general public for the first time in many years. Read more

Janssen Pharmaceutica partner of Move For Africa

05/03/2013

news item Now that national governments are slashing their budgets for development co-operation, Janssen Pharmaceutica wants to underline its solidarity with Africa. La Libre Belgique's Move for Africa campaign fits perfectly in this picture because both parties share the same mission: make a lasting and tangible difference in the world. Read more

Sirturo granted accelerated FDA approval in the U.S.

22/01/2013

news item On December 31, 2012 the U.S. Food and Drug Administration (FDA) granted SIRTURO™ (bedaquiline) accelerated approval for the treatment of pulmonary multi-drug resistant tuberculosis (MDR-TB) as part of a combination therapy in adults. MDR-TB is one of the deadliest and most difficult to treat forms of TB that affects approximately 630,000 people globally and is on the rise in many areas worldwide. Read more